| RS2107177965 |
PROS1
|
Health Risk |
Likely pathogenic |
— |
| RS2107189610 |
POC1A
|
Health Risk |
Pathogenic |
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome, Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome |
| RS2107192097 |
ARL13B
|
Health Risk |
Likely pathogenic |
Joubert syndrome 8, Joubert syndrome 8 |
| RS2107200636 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2107200789 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2107201024 |
FOXP1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2107201851 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2107202868 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS2107202922 |
PROS1
|
Health Risk |
Likely pathogenic |
Thrombophilia due to protein S deficiency, autosomal dominant |
| RS2107204142 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2107204955 |
CACNA2D2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2107207834 |
IMPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2107207943 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2107207948 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2107208049 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2107212252 |
FLNB
|
Health Risk |
Pathogenic |
— |
| RS2107212379 |
FLNB
|
Health Risk |
Pathogenic |
— |
| RS2107215447 |
ATRIP
|
Health Risk |
Pathogenic/Likely pathogenic |
Seckel syndrome, Microcephalic Primordial Dwarfism with immunodeficiency |
| RS2107220190 |
FLNB
|
Health Risk |
Likely pathogenic |
Larsen syndrome, Larsen syndrome |
| RS2107220476 |
FLNB
|
Health Risk |
Likely pathogenic |
— |
| RS2107222436 |
IMPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2107224888 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
Atelosteogenesis type I, Atelosteogenesis type I |
| RS2107224894 |
FLNB
|
Health Risk |
Pathogenic |
Atelosteogenesis type I, Atelosteogenesis type I |
| RS2107225016 |
FLNB
|
Health Risk |
Likely pathogenic |
— |
| RS2107225089 |
FLNB
|
Health Risk |
Likely pathogenic |
— |
| RS2107234582 |
IMPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2107250439 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type IV |
| RS2107250805 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS2107254550 |
TREX1
|
Health Risk |
Pathogenic |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, Aicardi-Goutieres syndrome 1 |
| RS2107255387 |
TREX1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 1, Aicardi-Goutieres syndrome 1 |
| RS2107255865 |
TREX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Chilblain lupus 1, Aicardi-Goutieres syndrome 1 |
| RS2107256093 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2107257357 |
PRKCD
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD |
| RS2107257487 |
PRKCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD |
| RS2107258834 |
TREX1
|
Health Risk |
Pathogenic |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, Aicardi-Goutieres syndrome 1 |
| RS2107262663 |
DOCK3
|
Health Risk |
Pathogenic |
— |
| RS2107263484 |
PRKCD
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD |
| RS2107265153 |
TREX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 1, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS2107265386 |
TREX1
|
Health Risk |
Likely pathogenic |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS2107265602 |
TREX1
|
Health Risk |
Likely pathogenic |
Thrombotic microangiopathy, Thrombotic microangiopathy |
| RS2107265977 |
TREX1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 1, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS2107267894 |
PRKCD
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD |
| RS2107279030 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal dominant |
| RS2107279041 |
PROS1
|
Health Risk |
Likely pathogenic |
Protein S deficiency disease, Protein S deficiency disease |
| RS2107279275 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS2107279407 |
PROS1
|
Health Risk |
Pathogenic |
Protein S deficiency disease, Protein S deficiency disease |
| RS2107298337 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS2107310071 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2107310122 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2107316329 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS2107337553 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107344308 |
FLNB
|
Health Risk |
Pathogenic |
— |
| RS2107346255 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107373870 |
DNASE1L3
|
Health Risk |
Likely pathogenic |
Autosomal systemic lupus erythematosus type 16, Autosomal systemic lupus erythematosus type 16 |
| RS2107397010 |
ROBO1
|
Health Risk |
Likely pathogenic |
Congenital anomaly of kidney and urinary tract, Congenital anomaly of kidney and urinary tract |
| RS2107413869 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107416290 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107416663 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107437335 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107445568 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107448208 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107453711 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2107478777 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS2107483632 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107483736 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107483975 |
MITF
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS2107489196 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107489383 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107502859 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107510544 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107511857 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107519404 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS2107519634 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS2107522179 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107525795 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS2107526111 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS2107526137 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS2107526347 |
LMOD3
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS2107526351 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS2107536775 |
MITF
|
Health Risk |
Likely pathogenic |
— |
| RS2107536936 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS2107537021 |
MITF
|
Health Risk |
Pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2107537096 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS2107548853 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2107552061 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS2107552171 |
MITF
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS2107565760 |
HESX1
|
Health Risk |
Pathogenic |
Septo-optic dysplasia sequence, GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES |
| RS2107566038 |
HESX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Septo-optic dysplasia sequence, GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES |
| RS2107575654 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2107578153 |
SETD2
|
Health Risk |
Pathogenic |
— |
| RS2107594330 |
ROBO1
|
Health Risk |
Likely pathogenic |
— |
| RS2107600390 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2107612882 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS2107612940 |
FOXP1
|
Health Risk |
Likely pathogenic |
— |
| RS2107613139 |
FOXP1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2107620082 |
PLXNA1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Dworschak-Punetha neurodevelopmental syndrome |
| RS2107620759 |
ROBO1
|
Health Risk |
Pathogenic |
Congenital anomaly of kidney and urinary tract, Congenital anomaly of kidney and urinary tract |
| RS2107624704 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107624870 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Familial hypocalciuric hypercalcemia |
| RS2107624936 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |